Your browser doesn't support javascript.
In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon ß-1a differed from standard care for in-hospital mortality.
Zhang, Raina; Mylonakis, Eleftherios.
  • Zhang R; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).
  • Mylonakis E; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA (R.Z., E.M.).
Ann Intern Med ; 174(2): JC17, 2021 02.
Article in English | MEDLINE | ID: covidwho-1526980

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Hospital Mortality / COVID-19 Subject: Antiviral Agents / Hospital Mortality / COVID-19 Type of study: Controlled clinical trial Language: English Journal: Ann Intern Med Clinical aspect: Therapy Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Hospital Mortality / COVID-19 Subject: Antiviral Agents / Hospital Mortality / COVID-19 Type of study: Controlled clinical trial Language: English Journal: Ann Intern Med Clinical aspect: Therapy Year: 2021
...